Internal Medicine, Hematology & Oncology · Port Jefferson Station, NY
NPI
1477843100
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
49 Nesconset Hwy
Port Jefferson Station, NY, 11776
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.8M
282,032 services
Medicare patients, 2024
2,538
Average age 77
Drug cost, 2024
$7.3M
1,904 prescriptions
Company payments, 2025
$82.65
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George Cyriac was code J1439 (injection, ferric carboxymaltose, 1 mg), 107,252 times for 112 patients. In total George Cyriac billed 282,032 services in 272 codes, and Medicare paid $3.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 107,252 | 112 | $0.88 | $94K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 17,101 | 26 | $2.29 | $39K |
| J1756 Injection, iron sucrose, 1 mg | Office | 14,000 | 41 | $0.18 | $2,457 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 12,000 | 20 | $44.44 | $533K |
| 88185 Surgical Pathology Examination | Office | 5,328 | 210 | $22.08 | $118K |
| J0897 Injection, denosumab, 1 mg | Office | 5,160 | 41 | $20.32 | $105K |
| 36415 Venipuncture Blood Collection | Office | 3,717 | 1,580 | $8.63 | $32K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,570 | 110 | $0.09 | $316 |
| 85025 Blood Count | Office | 3,541 | 1,489 | $7.60 | $27K |
| 80053 Clinical Chemistry | Office | 2,688 | 1,305 | $10.34 | $28K |
| 84100 Clinical Chemistry | Office | 2,135 | 1,041 | $4.64 | $9,898 |
| 83735 Clinical Chemistry | Office | 2,016 | 968 | $6.56 | $13K |
| 83615 Clinical Chemistry | Office | 1,941 | 949 | $5.91 | $11K |
| 84550 Clinical Chemistry | Office | 1,930 | 920 | $4.42 | $8,532 |
| 99214 Office E&M - Established | Office | 1,399 | 806 | $109.39 | $153K |
By year: 2022 $4.8M for 397,510 services; 2023 $4.7M for 343,065 services; 2024 $3.8M for 282,032 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 5,328 | 210 | $22.08 | $118K |
| 36415 Venipuncture Blood Collection | 3,717 | 1,580 | $8.63 | $32K |
| 85025 Blood Count | 3,541 | 1,489 | $7.60 | $27K |
| 80053 Clinical Chemistry | 2,688 | 1,305 | $10.34 | $28K |
| 84100 Clinical Chemistry | 2,135 | 1,041 | $4.64 | $9,898 |
| 83735 Clinical Chemistry | 2,016 | 968 | $6.56 | $13K |
| 83615 Clinical Chemistry | 1,941 | 949 | $5.91 | $11K |
| 84550 Clinical Chemistry | 1,930 | 920 | $4.42 | $8,532 |
| 82728 Clinical Chemistry | 1,344 | 794 | $13.32 | $18K |
| 83540 Clinical Chemistry | 1,325 | 782 | $6.32 | $8,377 |
Medicare prescription drug claims, 2024
In 2024, the drug George Cyriac prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 227 prescriptions and refills. In total George Cyriac wrote 1,904 Medicare prescriptions that cost $7.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 227 | 229 | 41 | $681K |
| Eliquis Apixaban | 161 | 241 | 44 | $137K |
| Akynzeo Fosnetupitant/Palonosetron | 119 | 119 | 27 | $122K |
| Warfarin Sodium Generic | 54 | 131 | Under 11 | $600 |
| Acyclovir Generic | 49 | 65 | 11 | $373 |
| Hydroxyurea Generic | 47 | 117 | 15 | $1,072 |
| Duloxetine Hcl Generic | 44 | 52 | Under 11 | $443 |
| Xgeva Denosumab | 44 | 48 | Under 11 | $138K |
| Anastrozole Generic | 35 | 75 | 15 | $904 |
| Letrozole Generic | 33 | 51 | Under 11 | $627 |
| Xarelto Rivaroxaban | 28 | 58 | 12 | $32K |
| Imbruvica Ibrutinib | 28 | 30 | Under 11 | $479K |
| Mvasi Bevacizumab-Awwb | 27 | 27 | Under 11 | $183K |
| Somatuline Depot Lanreotide Acetate | 26 | 26 | Under 11 | $247K |
| Revlimid Lenalidomide | 24 | 24 | Under 11 | $429K |
Brand drugs: 1,105 claims; generic drugs: 799 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George Cyriac $82.65 ($82.65 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genzyme Corporation with $29.51.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.